MCID: HDG009
MIFTS: 14

Hodgkin Lymphoma, Childhood malady

Categories: Rare diseases, Immune diseases

Aliases & Classifications for Hodgkin Lymphoma, Childhood

Aliases & Descriptions for Hodgkin Lymphoma, Childhood:

Name: Hodgkin Lymphoma, Childhood 50
Childhood Hodgkin's Lymphoma 50 69

Classifications:



Summaries for Hodgkin Lymphoma, Childhood

MalaCards based summary : Hodgkin Lymphoma, Childhood, also known as childhood hodgkin's lymphoma, is related to non-hodgkin lymphoma, childhood and hodgkin lymphoma. The drugs Cyclophosphamide and Lenograstim have been mentioned in the context of this disorder.

Related Diseases for Hodgkin Lymphoma, Childhood

Diseases related to Hodgkin Lymphoma, Childhood via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 non-hodgkin lymphoma, childhood 12.0
2 hodgkin lymphoma 9.6
3 lymphoma 9.6
4 pneumonia 9.6
5 childhood leukemia 9.6

Graphical network of the top 20 diseases related to Hodgkin Lymphoma, Childhood:



Diseases related to Hodgkin Lymphoma, Childhood

Symptoms & Phenotypes for Hodgkin Lymphoma, Childhood

Drugs & Therapeutics for Hodgkin Lymphoma, Childhood

Drugs for Hodgkin Lymphoma, Childhood (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 299)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
2
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
3
Thiotepa Approved Phase 4,Phase 2,Phase 1 52-24-4 5453
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
5
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
6
Vinblastine Approved Phase 4,Phase 2,Phase 1 865-21-4 13342 241903
7
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
8 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
9 Antilymphocyte Serum Phase 4,Phase 2,Phase 1
10 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
11 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
12 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
13 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1
14 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
15 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1
16 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1
17 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
18 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
19 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
20 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
21 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
22 Hormones Phase 4,Phase 3,Phase 2,Phase 1
23 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
24 Methylprednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1
25 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1
26 Neuroprotective Agents Phase 4,Phase 2,Phase 1
27 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1
28 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1
29 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1
30 Prednisolone phosphate Phase 4,Phase 3,Phase 2,Phase 1
31 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
32
Bleomycin Approved Phase 3,Phase 2 11056-06-7 5360373
33
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
34
Etoposide Approved Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
35
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
36
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
37
Cyclosporine Approved, Investigational, Vet_approved Phase 2, Phase 3, Phase 1 79217-60-0, 59865-13-3 5284373 6435893
38
Cytarabine Approved, Investigational Phase 2, Phase 3, Phase 1 147-94-4 6253
39
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
40
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3, Phase 1 22916-47-8 4189
41
Cisplatin Approved Phase 3,Phase 2 15663-27-1 84093 441203 2767
42
Dacarbazine Approved, Investigational Phase 3,Phase 2,Phase 1 4342-03-4 5351166
43
Procarbazine Approved Phase 3,Phase 2 671-16-9 4915
44
Busulfan Approved, Investigational Phase 3,Phase 2,Phase 1,Early Phase 1 55-98-1 2478
45
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
46
Vinorelbine Approved, Investigational Phase 3,Phase 1,Phase 2 71486-22-1 60780 44424639
47
Aldesleukin Approved Phase 2, Phase 3, Phase 1 85898-30-2, 110942-02-4
48
Carmustine Approved Phase 2, Phase 3,Phase 1 154-93-8 2578
49
Erythromycin Approved, Vet_approved Phase 3 114-07-8 12560
50
Pentamidine Approved Phase 3 100-33-4 4735

Interventional clinical trials:

(show top 50) (show all 241)
id Name Status NCT ID Phase
1 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4
2 Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma Recruiting NCT01088750 Phase 4
3 Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma Completed NCT01026220 Phase 3
4 Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma Completed NCT00070187 Phase 2, Phase 3
5 Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease Completed NCT00002827 Phase 3
6 Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease Completed NCT00005578 Phase 3
7 Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease Completed NCT00025259 Phase 3
8 Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma Completed NCT00433459 Phase 3
9 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3
10 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
11 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
12 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
13 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3
14 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3
15 Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease Completed NCT00003414 Phase 3
16 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer Completed NCT00002742 Phase 3
17 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
18 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
19 A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families Completed NCT00782145 Phase 3
20 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
21 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3
22 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3
23 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3
24 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
25 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3
26 Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases Completed NCT00438958 Phase 3
27 Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma Active, not recruiting NCT00302003 Phase 3
28 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Active, not recruiting NCT01987596 Phase 3
29 Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma Unknown status NCT00025064 Phase 2
30 Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders Unknown status NCT00008307 Phase 2
31 Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases Unknown status NCT00084695 Phase 2
32 Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma Unknown status NCT00621036 Phase 2
33 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
34 Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia Unknown status NCT00008164 Phase 2
35 Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation Unknown status NCT00036712 Phase 2
36 A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) Completed NCT00592111 Phase 2
37 Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma Completed NCT00416832 Phase 2
38 Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma Completed NCT00006029 Phase 1, Phase 2
39 Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma Completed NCT00003631 Phase 2
40 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease Completed NCT00004169 Phase 2
41 Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma Completed NCT00398554 Phase 2
42 Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy Completed NCT00381940 Phase 2
43 Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer Completed NCT00049504 Phase 2
44 Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma Completed NCT00006760 Phase 2
45 Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma Completed NCT00070304 Phase 2
46 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00489203 Phase 2
47 Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease Completed NCT00004010 Phase 2
48 Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00027937 Phase 2
49 Study of @neWorld: A Virtual Community for Children With Cancer Completed NCT00070421 Phase 1, Phase 2
50 Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma Completed NCT00238433 Phase 2

Search NIH Clinical Center for Hodgkin Lymphoma, Childhood

Genetic Tests for Hodgkin Lymphoma, Childhood

Anatomical Context for Hodgkin Lymphoma, Childhood

Publications for Hodgkin Lymphoma, Childhood

Variations for Hodgkin Lymphoma, Childhood

Expression for Hodgkin Lymphoma, Childhood

Search GEO for disease gene expression data for Hodgkin Lymphoma, Childhood.

Pathways for Hodgkin Lymphoma, Childhood

GO Terms for Hodgkin Lymphoma, Childhood

Sources for Hodgkin Lymphoma, Childhood

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....